Press Releases Myconic Capital Corp. Toronto S.E.

Equities

MEDI

CA62848M1077

End-of-day quote Toronto S.E. Other stock markets 23:00:00 07/02/2021 GMT			5-day change	1st Jan Change
0.6 ^CAD	-40.00%		-14.29%	+66.67%

2023	Cardinal Group Companies LLC entered into an agreement to acquire KGK Science Inc. from Wellbeing Digital Sciences Inc. for $2 million.	CI
2023	Wellbeing Digital Sciences Inc.'s Wholly Owned Subsidiary KGK Sciences Inc Begins Recruitment in First-Of-Its-Kind Health Canada Approved Psilocybin Trial	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Wellbeing Digital Subsidiary KGK Science to Participate at the Mushroom Summit and Psychedelic Science Conference	19/06/23	BU
Wellbeing Digital Enters into Share Purchase Agreement with Cardinal Group	16/06/23	BU
Wellbeing Digital Subsidiary KGK Science to Participate at the Nutrition Industry Association Spring Conference	25/05/23	BU
Wellbeing Subsidiary KGK Science Announces Successful Results of UP360, a Nutraceutical Ingredient Demonstrating Beneficial Immune Defense Response	03/05/23	BU
Wellbeing Subsidiary KGK Science Begins Recruitment in First-of-its-Kind Health Canada Approved Psilocybin Trial	18/04/23	BU
Wellbeing Subsidiary KGK Science Receives Institutional Review Board Approval	11/04/23	BU
Wellbeing Announces Cease Trade Order	06/04/23	BU
IIROC Trading Halt - MEDI	06/04/23	AQ
Wellbeing Provides Bi-Weekly Default Status Report	16/03/23	BU
Wellbeing Digital to Participate at the Benzinga Psychedelic Capital Conference	16/03/23	BU
Wellbeing Digital to Participate at the Cantor Fitzgerald Virtual Panel Discussion	13/03/23	BU
Wellbeing Digital to Participate in The Global Biomedical Design Conference	09/03/23	BU
Wellbeing Subsidiary KGK Science Applies for a Controlled Substances Dealers License and Receives Approval to Proceed with Buildout	08/03/23	BU
Wellbeing Provides Bi-Weekly Default Status Report	02/03/23	BU
Wellbeing Digital to Participate in MarigoldLIVE: International Women’s Day Networking Event	01/03/23	BU
Wellbeing Provides Bi-Weekly Default Status Report	16/02/23	BU
Wellbeing Subsidiary KGK Science Announces Publication of Safety Studies on Paraxanthine and Comparison to Caffeine Toxicity.	15/02/23	BU
Wellbeing Subsidiary KGK Science Receives Exemption Under Section 56 of the Controlled Drugs and Substances Act to Begin Psilocybin Clinical Trial	14/02/23	BU
Wellbeing Announces Delay in Filing Its Financial Statements and Management Cease Trade Order	01/02/23	BU
Wellbeing Digital to Participate in the Psychedelic Medicine Association Webinar	25/01/23	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Myconic Capital Corp. Toronto S.E.

Equities

MEDI

CA62848M1077

Press Releases

Filters